| Cell line name |
TH-111 |
|---|
| Accession |
CVCL_WP01 |
|---|
| Resource Identification Initiative |
To cite this cell line use: TH-111 (RRID:CVCL_WP01) |
|---|
| Comments |
Monoclonal antibody isotype: IgG1, kappa.
Monoclonal antibody target: UniProtKB; P40200; Human CD96. |
|---|
| Species of origin |
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
|---|
| Hierarchy |
Parent: CVCL_2199 (Sp2/0-Ag14) |
|---|
| Category |
Hybridoma |
|---|
| Publications | PubMed=9845376
Martin Gramatzki, Wolf-Dieter Ludwig, Renate Burger, Pia Moos, Peter Rohwer, Christine Grunert, Andrea Sendler, Joachim Robert Kalden, Reinhard Andreesen, Frank Henschke, Gerhard Moldenhauer;
Antibodies TC-12 ('unique') and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.
Exp. Hematol. 26:1209-1214(1998) PubMed=22879978; DOI=10.1371/journal.pone.0042426; PMCID=PMC3411760
Sahar Mohseni Nodehi, Roland Repp, Christian Kellner, Joachim Brautigam, Matthias Staudinger, Natalie Schub, Matthias Peipp, Martin Gramatzki, Andreas Humpe;
Enhanced ADCC activity of affinity maturated and Fc-engineered mini-antibodies directed against the AML stem cell antigen CD96.
PLoS ONE 7:e42426.1-e42426.13(2012) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q98133233
|
|---|
| Entry history |
|---|
| Entry creation | 05-Jul-2019 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 3 |
|---|
